Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker. [electronic resource]
- Hypertension (Dallas, Tex. : 1979) Jun 2012
- 1204-11 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1524-4563
10.1161/HYP.0b013e31825b30f8 doi
Adult Black or African American--genetics Angiotensin II Type 1 Receptor Blockers--therapeutic use Benzimidazoles--therapeutic use Biphenyl Compounds Blood Pressure--drug effects Case-Control Studies Chi-Square Distribution Chromosomes, Human, Pair 11--genetics Chromosomes, Human, Pair 16--genetics Diuretics--therapeutic use Drug Administration Schedule Epithelial Sodium Channels--genetics Female Genetic Predisposition to Disease--genetics Genome-Wide Association Study--methods Genotype Humans Hydrochlorothiazide--therapeutic use Hypertension--drug therapy Male Middle Aged Polymorphism, Single Nucleotide Receptors, G-Protein-Coupled--genetics Renin-Angiotensin System--genetics Tetrazoles--therapeutic use White People--genetics